Amgen’s Contagious Relationships Spread Industrywide
“This is where it gets contagious,” says Rodney A. MacLea, Amgen’s supply chain director.
But MacLea isn’t alarmed; this contagion is nourishing. Actually, it’s a follow-on effect from Amgen’s open communication in supplier relationships – and the company’s willingness to share the spoils born from that openness.
“It started when one of our suppliers took this concept to heart, and applied it to their network,” explains MacLea. “They were having yield issues, and of their own accord identified two parameters in a process they needed to control with their materials suppliers. When they proactively did that, problems started to go away and our supply stabilized.” Notably, both sides benefitted long-term from the efforts.
In an initial article with MacLea, I referred to Amgen’s supplier-relationship approach as a bilateral commitment to continuing operational excellence. Here’s how it works, and moreover, how the contagion needs to spread throughout the entire biopharma industry.
Source: Pharmaceutical Online